Eishi Motomura
Overview
Explore the profile of Eishi Motomura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
618
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shiroyama T, Maeda M, Tanii H, Motomura E, Okada M
Brain Sci
. 2025 Feb;
15(2).
PMID: 40002441
Background/objectives: Recent studies indicate extensive shared white matter (WM) abnormalities between bipolar disorder (BD) and schizophrenia (SZ). However, the heterogeneity of WM in BD in terms of the presence of...
2.
Okubo R, Matsumoto R, Motomura E, Okada M
Int J Environ Res Public Health
. 2024 Oct;
21(10).
PMID: 39457339
Standardized suicide mortality rates per 100,000 (SMRs) in Japan consistently decreased from 2009 to 2019 but increased from 2020. The causes of these temporal SMR fluctuations remain to be clarified....
3.
Motomura E, Inui K, Okada M
Neuroscience
. 2024 Oct;
561:119-126.
PMID: 39426706
A periodic sound with a fixed inter-stimulus interval elicits an auditory steady-state response (ASSR). An abrupt change in a continuous sound is known to affect the brain's ongoing neural oscillatory...
4.
Okubo R, Okada M, Motomura E
Biomolecules
. 2024 Sep;
14(9).
PMID: 39334894
For several decades, the dopamine hypothesis contributed to the discovery of numerous typical and atypical antipsychotics and was the sole hypothesis for the pathophysiology of schizophrenia. However, neither typical nor...
5.
Okada M, Fukuyama K, Motomura E
Br J Pharmacol
. 2024 Aug;
181(22):4571-4592.
PMID: 39091175
Background And Purpose: Clozapine is an effective antipsychotic for treatment-resistant schizophrenia, but its discontinuation leads to discontinuation syndrome/catatonia complicated by benzodiazepine-resistance and rhabdomyolysis. Experimental Approach: This study determined time-dependent effects...
6.
Okada M, Matsumoto R, Motomura E
PCN Rep
. 2024 Jun;
3(2):e188.
PMID: 38868081
Statistical analyses from Japan reported increasing suicides in 2020, first in the world, proving the severity of the public health crisis during the COVID-19 pandemic; however, so far, international suicides...
7.
Matsumoto R, Motomura E, Okada M
Int J Environ Res Public Health
. 2024 Apr;
21(4).
PMID: 38673410
Standardized suicide mortality rates per 100,000 population (SMRs) in Japan consistently decreased from 2009-2019, but these decreasing trends were reversed to increase in 2020. To clarify the mechanisms of recent...
8.
Matsumoto R, Motomura E, Okada M
Eur J Investig Health Psychol Educ
. 2024 Apr;
14(4):1086-1100.
PMID: 38667826
In Japan, suicide mortalities consistently decreased before the COVID-19 pandemic (from 2009 to 2019) but, conversely, increased after the pandemic outbreak from 2020 to 2022. To provide up-to-date suicide statistics...
9.
Inui K, Takeuchi N, Borgil B, Shingaki M, Sugiyama S, Taniguchi T, et al.
Front Neurosci
. 2024 Apr;
18:1378619.
PMID: 38655109
Responses to a sensory stimulus are inhibited by a preceding stimulus; if the two stimuli are identical, paired-pulse suppression (PPS) occurs; if the preceding stimulus is too weak to reliably...
10.
Fukuyama K, Motomura E, Okada M
Biomolecules
. 2024 Feb;
14(2).
PMID: 38397441
To explore the developmental processes of epileptogenesis/ictogenesis, this study determined age-dependent functional abnormalities associated with purinergic transmission in a genetic rat model (S286L-TG) of autosomal-dominant sleep-related hypermotor epilepsy (ADSHE). The...